
南美洲和中美洲关节疼痛注射市场预测至 2028 年 - COVID-19 影响和药物(透明质酸、皮质类固醇等)、关节类型(膝、足、踝、肩肘、髋等)的区域分析和分销渠道(零售药店、医院药房等)
No. of Pages: 114 | Report Code: TIPRE00024552 | Category: Life Sciences
No. of Pages: 114 | Report Code: TIPRE00024552 | Category: Life Sciences
南美洲和中美洲关节止痛注射 市场是
巴西的 COVID-19 病例数量史无前例地增加,导致停止了包括关节疼痛注射剂在内的各种医疗保健产品的多项业务运营和制造活动,这对关节疼痛注射剂市场产生了负面影响。南美洲相当多的国家医疗基础设施非常不发达。此外,该地区关节疼痛注射的可用性也明显较低。例如,秘鲁的 3200 万居民只有不到 1000 个重症监护病房床位。此外,由于港口拥堵和其他运输方式的干扰而造成的供应链中断对该地区关节疼痛注射剂的分销产生了重大影响。所有这些因素都极大地阻碍了南美洲和中美洲关节疼痛注射剂市场的增长。
南美洲和中美洲的关节疼痛注射剂市场预计将从2021年的1.2478亿美元增长到2028年的1.9941亿美元;预计 2021 年至 2028 年复合年增长率为 6.9%。巴西是世界上面积和人口第五大国,也是全球人口老龄化最快的国家。在巴西,在区域和历史社会经济不平等的背景下,人口老龄化速度很快。根据在巴西进行的研究,妇女群体估计占绝大多数,老年人口数量为 1,690 万(56%),而老年人估计约有 1,690 万(56%)。 1330 万(44%)。人口老龄化的加剧导致骨科疾病的发病率不断增加。这种不断增长的情况可能会推动医疗设备的采用,最终将在预测期内推动巴西关节疼痛注射市场的发展。与巴西类似,阿根廷也是该地区最大的国家。该国在医疗设备行业中发挥着至关重要的作用。该国必须经历私营和公共医疗保健部门的发展。此外,阿根廷正在通过所有医疗保健领域的高技能专业人员加强人力资源。阿根廷提供高质量的医疗服务,被认为是拉丁美洲最好的医疗服务之一。在布宜诺斯艾利斯、科尔多瓦或门多萨等城市,医院和诊所拥有先进的基础设施和合格的医务人员。因此,预计该国拥有巨大的市场增长机会。
按药品分,2020年南美洲和中美洲关节痛注射液市场份额最大的是玻尿酸细分市场。按关节类型分,膝关节细分市场占南美洲和中美洲最大份额2020年关节痛注射剂市场。从分销渠道来看,2020年南美洲和中美洲关节痛注射剂市场中医院药房占据最大份额。
<强>主要来源和上市公司
在准备南美洲和中美洲关节疼痛注射市场报告时提到的一些主要一手和二手来源是公司网站、年度报告、财务报告、国家政府文件、统计数据库等。报告中列出的主要公司包括Bioventus Inc.; Fidia Pharma 美国公司;生化学株式会社;辉凌有限公司;赛诺菲;阿尼卡治疗公司;和 Teva Pharmaceutical Industries Ltd.
Strategic insights for South and Central America Joint Pain Injection involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Report Attribute | Details |
---|---|
Market size in 2021 | US$ 124.78 Million |
Market Size by 2028 | US$ 199.41 Million |
Global CAGR (2021 - 2028) | 6.9% |
Historical Data | 2019-2020 |
Forecast period | 2022-2028 |
Segments Covered |
By 药物
|
Regions and Countries Covered | 南美洲和中美洲
|
Market leaders and key company profiles |
The regional scope of South and Central America Joint Pain Injection refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The South and Central America Joint Pain Injection Market is valued at US$ 124.78 Million in 2021, it is projected to reach US$ 199.41 Million by 2028.
As per our report South and Central America Joint Pain Injection Market, the market size is valued at US$ 124.78 Million in 2021, projecting it to reach US$ 199.41 Million by 2028. This translates to a CAGR of approximately 6.9% during the forecast period.
The South and Central America Joint Pain Injection Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South and Central America Joint Pain Injection Market report:
The South and Central America Joint Pain Injection Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The South and Central America Joint Pain Injection Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the South and Central America Joint Pain Injection Market value chain can benefit from the information contained in a comprehensive market report.